Navigation Links
synthesis - Don't Build Programs That Ignore Your Goals - Absurdity
Date:11/13/2009

SEATTLE, Nov. 13 /PRNewswire/ -- The following blog post was published November 8, 2009, by Shafeen Charania, author of the synthesis blog, winner of the 2008 Weblog award for best new blog, and Time.com's 25 best blogs of 2009.

The foremost reason for healthcare reform in America is balancing inequity - ensuring that those that are un- or under-covered have coverage. Knowing that at least two challenges facing these communities are obesity and unwanted pregnancies, how is it that the House is able to pass legislation that doesn't address their specific needs?

To learn more, please visit: http://interacc.typepad.com/synthesis/2009/11/absurdity.html.

SOURCE synthesis


'/>"/>
SOURCE synthesis
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. synthesis - Whats the Real Objective - Outcomes!
2. Trans Ionics Announces New Service - Custom Separation Synthesis (CSS)(TM)
3. Digital mammography plus digital breast tomosynthesis may decrease patient recall rates
4. Orochem Technologies Acquires Oligonet, a Custom Oligo Synthesis Business
5. Kinovate Life Sciences, Inc. and Nitto Denko Corporation Announce Successful Development of NittoPhase™ HL High Loading Solid Support for Oligonucleotide Synthesis
6. Microwave synthesis connects with the (quantum) dots
7. Thomson Reuters Adds Routes of Synthesis Data to Its Newport Horizon Premium and Newport Vision Premium Solutions
8. Synthesis of natural molecule could lead to better anti-cancer drugs
9. Scientific Journal Gene Therapy Reports That Cardiums Gene Activated Matrix Technology Accelerates Periodontal Tissue Regeneration
10. Florida Gentle Dental Dentists Giving Away Smile Makeover and Orthodontic Braces at 7th Annual Our Kids World Family Fun Festival
11. Patients with moderate to severe periodontitis need evaluation for heart disease risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2017)... Plano, Texas (PRWEB) , ... May 26, 2017 , ... ... Cord Stimulation System, a powerfully versatile, patient-centric spinal cord stimulation system. The Nuvectra™ Algovita ... , “We are pleased to be the first in Arkansas to introduce the ...
(Date:5/26/2017)... ... May 26, 2017 , ... via ... antimicrobial, mesh back 24/7 task chair specifically designed for clinical areas. Genie Copper ... thrilled to partner with Cupron® to provide customers with a game changing chair ...
(Date:5/26/2017)... Illinois (PRWEB) , ... May 26, 2017 , ... Silver ... The community, which is located on more than four acres of land at 5620 ... independence. , The 103,000 square-foot building includes 125 studio and one-bedroom apartments. Each ...
(Date:5/26/2017)... (PRWEB) , ... May 26, 2017 , ... “THE FLINTHILLS FAMILY-Our Journey to the Cross”: ... FAMILY-Our Journey to the Cross” is the creation of published authors, Bob and Margaret Massey. ... used to say, he is "panther quick and leather tough." His love for others ...
(Date:5/26/2017)... ... ... Water damage to the flooring of several classrooms at The Fort Lee Elementary ... number of critical issues to address before students could return to classes. , First, ... no disruption to class schedules. Second, the project had to comply with New Jersey ...
Breaking Medicine News(10 mins):
(Date:5/22/2017)... Fla. , May 22, 2017  As ... as a whole continue to make the revolutionary ... becomes increasingly important for ensuring positive patient outcomes ... industry stakeholders are shifting focus away from clinical ... and effects of long-term specialty drug therapy utilization ...
(Date:5/18/2017)... 2017  Bayer announced today that the latest research ... at the 53 rd Annual Meeting of the ... 2-6 in Chicago . ... colorectal, liver and thyroid cancers, as well as lymphomas, ... CHRONOS-1 trial of copanlisib in patients with relapsed or ...
(Date:5/15/2017)... , May 15, 2017 Enterin Inc., a privately-held ... and developing novel compounds to treat Parkinson,s disease (PD), has ... is a Phase 1/2a randomized, controlled, multicenter study involving patients ... will enroll 50 patients over a 9-to-12-month period. The first ... 10 patients with PD. Participating sites include Denver ...
Breaking Medicine Technology: